AngioWaveNet vs KardiaAI
AI Verdict
Choose AngioWaveNet if…
Choose AngioWaveNet if your cardiac catheterization lab requires AI-powered enhancement of fluoroscopic angiograms for improved vessel visualization during interventional procedures. This tool is ideal for integrating seamlessly with existing cath lab workflows and any angiography system to enhance the visibility of blood vessels and anatomical features.
View AngioWaveNet →Choose KardiaAI if…
Choose KardiaAI if you need an FDA-cleared AI software library for automated analysis of ambulatory ECG rhythms to detect various cardiac conditions. This solution is best suited for integration into mobile apps or web platforms that process ECG data, providing medical-grade accuracy for identifying arrhythmias like AFib, bradycardia, and tachycardia.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AngioWaveNet | KardiaAI |
|---|---|---|
| Pricing | Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. | Subscription-based for advanced features and services. |
| Deployment | Cloud-based or on-premise/servers | Mobile app, cloud-based. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AngioWaveNetAngioWaveNet is designed for seamless integration into existing Cath lab workflows, offering vendor-agnostic compatibility and functioning as a DICOM endpoint, which minimizes disruption and training for specialists. Its 'light footprint' and quick configuration further enhance its usability within a complex hospital environment. While KardiaAI's associated products are user-friendly for patients, its app's reliance on subscriptions for full functionality can detract from the overall user experience.
Clinical Value
KardiaAIBoth tools are FDA-cleared and provide significant clinical value. AngioWaveNet enhances vessel visualization in angiograms, aiding diagnostic and procedural guidance. However, KardiaAI, particularly with its Kardia 12L system, offers a broader diagnostic scope, detecting 39 cardiac determinations, including heart attacks, with accuracy comparable to standard 12-lead ECGs. This comprehensive and impactful diagnostic capability for a wider range of life-threatening conditions gives KardiaAI a stronger clinical value proposition.
Pricing & Value
KardiaAIKardiaAI offers transparent and accessible subscription pricing for its services, with clear monthly and annual options, making its value proposition readily understandable for individual users and smaller practices. AngioWaveNet's pricing is customized for enterprise-level hospital needs, which, while flexible, lacks the public transparency for direct value comparison.
Enterprise Readiness
KardiaAIBoth tools demonstrate strong enterprise readiness with FDA clearance and HIPAA compliance. AngioWaveNet offers vendor-agnostic compatibility and flexible deployment options for existing Cath lab infrastructure. However, KardiaAI provides a comprehensive enterprise platform (KardiaPro) with explicit EHR integration, including being listed in Epic's App Orchard Marketplace, and offers a Business Associate Agreement (BAA), indicating robust readiness for broader healthcare system integration and remote patient monitoring.
Innovation
KardiaAIBoth are innovative, with AngioWaveNet applying AI to enhance angiography in a field with historically little innovation. However, KardiaAI (through AliveCor's products) has a consistent track record of disruptive innovation, including the world's first credit-card-sized personal ECG and the first AI-powered handheld 12-lead ECG system capable of detecting heart attacks with a reduced leadset. This consistent introduction of groundbreaking, accessible technologies gives KardiaAI the edge in innovation.
Support & Docs
KardiaAIKardiaAI offers a more comprehensive support and documentation ecosystem, including a detailed 'Resource Hub' with studies and publications, extensive FAQs, user manuals, and direct customer support via phone and email. Additionally, it features an AI-powered virtual assistant, AskKardia, for instant guidance. AngioWaveNet's public information on support and documentation is less extensively detailed.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AngioWaveNet | KardiaAI |
|---|---|---|
| Name | AngioWaveNet | KardiaAI |
| Company | Angiowave Imaging | AliveCor |
| Description | FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, integrating with existing Cath lab workflows. | FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia. |
| Primary Function | AI-powered Spatiotemporal Enhancement Processing (STEPu2122) for improved vessel visualization in fluoroscopic angiograms | AI-powered ECG analysis library for detection of atrial fibrillation, bradycardia, tachycardia, and other cardiac conditions |
| Specialties | Cardiology, Interventional Radiology, Vascular Surgery | Cardiology, Emergency Medicine, Internal Medicine |
| Vendor Agnostic | Compatible with any fluoroscopic angiography system (vendor-agnostic) | Not specified |
Videos
Demos, reviews, and walkthroughs featuring AngioWaveNet and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring AngioWaveNet or KardiaAI
Backers
Who funded each tool's parent company.